A real-world analysis finds minimally invasive canaloplasty for glaucoma lowers intraocular pressure by 20% or more in half ...

Eye health company Bausch & Lomb is recalling some of its intraocular lenses over possible safety concerns. The voluntary ...

Although its pathogenesis is multifactorial, with age, genetics, and blood flow playing key roles, reducing intraocular pressure (IOP) remains the only modifiable risk factor. Therefore ...

The bio-interventional platform is for uveoscleral outflow enhancement in open-angle glaucoma patients undergoing combined ...

Nanoscope Therapeutics has said it plans to seek regulatory approval for its advanced retinitis pigmentosa gene therapy MCO-010 early this year.

The following is a summary of “Adjuvant Brachytherapy Using Iodine-125 Plaques for Conjunctival Melanoma with Scleral ...

Press Release Nicox Announces Last Patient Completes Final Visit in NCX 470 Phase 3b Whistler Glaucoma Trial Results expected in May 2025 Last ...

Sight Sciences’ management is scheduled to present on Tuesday, April 8, 2025, at 12:45 pm PT / 3:45 pm ET. Interested parties may access a live and archived webcast of the fireside chat on the ...

Generic Cosopt is indicated for the reduction of elevated intraocular pressure in patients with open-angle glaucoma or ocular ...